Adial Pharmaceuticals (ADIL) Current Leases (2021 - 2023)
Adial Pharmaceuticals (ADIL) posted Current Leases of $58751.0 for Q1 2023, up 3.38% sequentially from $56828.0 in Q4 2022, and up 14.41% YoY from $51351.0 in Q1 2022.
Adial Pharmaceuticals (ADIL) Current Leases (2021 - 2023) Analysis & Trends
Adial Pharmaceuticals has reported Current Leases for 3 years, with the latest figure at $58751.0 in Q1 2023.
- Quarterly Current Leases rose 14.41% year-over-year to $58751.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $58751.0 (up 14.41% YoY) and the FY2022 annual result came in at $56828.0, up 14.61% from the prior year.
- Current Leases advanced to $58751.0 in Q1 2023 per ADIL's latest filing, from $56828.0 in the prior quarter.
- Over five years, Current Leases peaked at $58751.0 in Q1 2023 and troughed at $44403.0 in Q1 2021.
- A 3-year average of $51436.2 and a median of $51351.0 in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2023: Current Leases climbed 15.65% in 2022, then increased 14.41% in 2023.
- Over 3 years, Current Leases stood at $49585.0 in 2021, then gained by 14.61% to $56828.0 in 2022, then gained by 3.38% to $58751.0 in 2023.
- According to Business Quant data, Current Leases over the past three periods registered $58751.0, $56828.0, and $54961.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Adial Pharmaceuticals | 28.42 Mn | 28.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 58,751.00 |
| Dec 31, 2022 | 56,828.00 |
| Sep 30, 2022 | 54,961.00 |
| Jun 30, 2022 | 53,136.00 |
| Mar 31, 2022 | 51,351.00 |
| Dec 31, 2021 | 49,585.00 |
| Sep 30, 2021 | 47,819.00 |
| Jun 30, 2021 | 46,092.00 |
| Mar 31, 2021 | 44,403.00 |